NAS:MLTX (Switzerland)
Â
Class A
$
44.96
-0.14 (-0.31%)
08:09 PM EST
Business Description
MoonLake Immunotherapeutics
NAICS : 541720
SIC : 2833
ISIN : KY61559X1045
Share Class Description:
MLTX: Class ADescription
MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 149.43 | |||||
Equity-to-Asset | 0.96 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.06 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate | -56.67 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.28 | |||||
9-Day RSI | 50.41 | |||||
14-Day RSI | 52.86 | |||||
6-1 Month Momentum % | -29.71 | |||||
12-1 Month Momentum % | -31.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 62.12 | |||||
Quick Ratio | 62.12 | |||||
Cash Ratio | 61.39 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -17.86 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -10.19 | |||||
ROA % | -9.4 | |||||
ROIC % | -906.86 | |||||
ROC (Joel Greenblatt) % | -3423.03 | |||||
ROCE % | -14.38 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 5.19 | |||||
Price-to-Tangible-Book | 5.21 | |||||
EV-to-EBIT | -37.48 | |||||
EV-to-EBITDA | -37.5 | |||||
EV-to-Forward-Revenue | 30.21 | |||||
EV-to-FCF | -46.75 | |||||
Price-to-Net-Current-Asset-Value | 5.31 | |||||
Price-to-Net-Cash | 5.38 | |||||
Earnings Yield (Greenblatt) % | -2.67 | |||||
FCF Yield % | -1.74 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MLTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MoonLake Immunotherapeutics Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.73 | ||
Beta | 0 | ||
Volatility % | 55.21 | ||
14-Day RSI | 52.86 | ||
14-Day ATR ($) | 2.341203 | ||
20-Day SMA ($) | 44.7585 | ||
12-1 Month Momentum % | -31.9 | ||
52-Week Range ($) | 35.11 - 64.98 | ||
Shares Outstanding (Mil) | 62.87 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
MoonLake Immunotherapeutics Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
MoonLake Immunotherapeutics Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
MoonLake Immunotherapeutics Frequently Asked Questions
What is MoonLake Immunotherapeutics(MLTX)'s stock price today?
The current price of MLTX is $44.96. The 52 week high of MLTX is $64.98 and 52 week low is $35.11.
When is next earnings date of MoonLake Immunotherapeutics(MLTX)?
The next earnings date of MoonLake Immunotherapeutics(MLTX) is 2024-08-09 Est..
Does MoonLake Immunotherapeutics(MLTX) pay dividends? If so, how much?
MoonLake Immunotherapeutics(MLTX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |